Citius OncologyCTOR
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 11 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings, up 4 from Q3 2024. 5 opened new positions and 1 sold out. The largest holders were HRT Financial LP ($78K), UBS Group AG ($29K) and Citadel Advisors ($26K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Citius Oncology Inc.
- CUSIP
- 17331Y109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $156K |
| Exits | 1 | $14K |
All 13F filers, Q3 2024 → Q4 2024: 173,437 shares bought and 13,791 shares sold, net +159,646 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| HRT Financial LP | 0.00% | New | 68,543 | $78K |
| UBS Group AG | 0.00% | Add +1419.9% | 24,805 | $29K |
| Citadel Advisors | 0.00% | New | 22,699 | $26K |
| IFP Advisors, Inc | 0.00% | Add +173.1% | 22,215 | $26K |
| XTX Topco Ltd | 0.00% | New | 21,095 | $24K |
| Geode Capital Management, LLC | 0.00% | New | 12,651 | $15K |
| Yakira Capital Management, Inc. | 0.01% | Reduce -22.6% | 11,999 | $14K |
| Renaissance Technologies | 0.00% | New | 11,196 | $13K |
| Osaic Holdings, Inc. | 0.00% | No change | 5,480 | $6K |
| Bank of America Corp. | 0.00% | No change | 160 | $184 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 41 | $47 |
"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.